AU2001273239A1 - Transporters and ion channels - Google Patents

Transporters and ion channels

Info

Publication number
AU2001273239A1
AU2001273239A1 AU2001273239A AU7323901A AU2001273239A1 AU 2001273239 A1 AU2001273239 A1 AU 2001273239A1 AU 2001273239 A AU2001273239 A AU 2001273239A AU 7323901 A AU7323901 A AU 7323901A AU 2001273239 A1 AU2001273239 A1 AU 2001273239A1
Authority
AU
Australia
Prior art keywords
transporters
ion channels
channels
ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273239A
Other languages
English (en)
Inventor
Chandra S. Arvizu
Janice Au-Young
Yalda Azimzai
Mariah R. Baughn
Mark L. Borowsky
Neil Burford
Narinder K. Chawla
Debopriya Das
Li Ding
Vicki S. Elliott
Ameena R. Gandhi
Barrie D. Greene
April J. A. Hafalia
Lee Harland
Liam Kearney
Farrah A. Khan
Preeti Lal
Dyung Aina M. Lu
Yan Lu
Danniel B. Nguyen
Jennifer L. Policky
Jayalaxmi Ramkumar
Brigitte E. Raumann
Madhu S. Sanjanwala
Jeffrey J. Seilhamer
Y. Tom Tang
Kavitha Thangavelu
Michael Thornton
Catherine M. Tribouley
Roderick T. Walsh
Yuming Xu
Junming Yang
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001273239A1 publication Critical patent/AU2001273239A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001273239A 2000-07-07 2001-07-05 Transporters and ion channels Abandoned AU2001273239A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US21654700P 2000-07-07 2000-07-07
US60/216,547 2000-07-07
US21823200P 2000-07-14 2000-07-14
US60/218,232 2000-07-14
US22011200P 2000-07-21 2000-07-21
US60/220,112 2000-07-21
US22183900P 2000-07-28 2000-07-28
US60/221,839 2000-07-28
PCT/US2001/021448 WO2002004520A2 (en) 2000-07-07 2001-07-05 Transporters and ion channels

Publications (1)

Publication Number Publication Date
AU2001273239A1 true AU2001273239A1 (en) 2002-01-21

Family

ID=27499045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273239A Abandoned AU2001273239A1 (en) 2000-07-07 2001-07-05 Transporters and ion channels

Country Status (5)

Country Link
EP (1) EP1313854A2 (de)
JP (1) JP2004513618A (de)
AU (1) AU2001273239A1 (de)
CA (1) CA2415808A1 (de)
WO (1) WO2002004520A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236389A1 (en) * 2000-12-15 2003-12-25 Shimkets Richard A. Proteins, polynucleotides encoding them and methods of using the same
US6586179B1 (en) * 1999-07-13 2003-07-01 Icagen, Incorporated Human Eag2
AU2001241446A1 (en) * 2000-02-03 2001-08-14 Lexicon Genetics Incorporated Human transporter proteins and polynucleotides encoding the same
US20020132298A1 (en) * 2000-11-14 2002-09-19 Millennium Pharmaceuticals, Inc. 67118, 67067, and 62092, human proteins and methods of use thereof
US20020042100A1 (en) * 2000-07-03 2002-04-11 Chunhua Yan Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
WO2002024744A2 (en) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. 49938, a human phospholipid transporter and uses therefor
GB2372503A (en) * 2000-10-19 2002-08-28 Glaxo Group Ltd Voltage-gated potassium channel polypeptides
CA2428979A1 (en) * 2000-11-20 2002-05-30 Merck & Co., Inc. Human erg2 potassium channel
US20020103337A1 (en) * 2000-12-04 2002-08-01 Chunhua Yan Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
UA79927C2 (en) * 2000-12-05 2007-08-10 Serono Genetics Inst Sa Polynucleotide, coding a polypeptide of potential-depending portal ionic human channel (canion), polypeptyde, antibody, method for identification of candidate modulator of canion-polypeptyde, method for treatment of bipolar disorder or schizophrenia and use of an antibody for production of drugs for treatment of schizophrenia or bipolar disorder
JP2005501505A (ja) * 2000-12-12 2005-01-20 ピーイー コーポレイション （エヌワイ） 単離ヒト輸送体タンパク質、ヒト輸送体タンパク質をコードする核酸分子、およびそれらの使用方法
WO2002050300A2 (en) * 2000-12-20 2002-06-27 Merck & Co., Inc. Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3
JP3997912B2 (ja) * 2000-12-27 2007-10-24 アステラス製薬株式会社 新規カリウムチャネル
CA2435828A1 (en) * 2001-01-22 2002-10-10 Pe Corporation (Ny) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
EP1273660A3 (de) * 2001-01-30 2004-01-07 Aeomica, Inc. Menschliches Natrium-Wasserstoff-Austauscher-ähnliches Protein 1
GB2390093A (en) * 2001-01-30 2003-12-31 Aeomica Inc Human sodium-hydrogen exchanger like protein 1
US20020142378A1 (en) * 2001-03-21 2002-10-03 Hongyu Zhang Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
GB2377445A (en) * 2001-04-20 2003-01-15 Smithkline Beecham Plc Ion channel vanilloid receptor, VANILREP7
EP1258496A1 (de) * 2001-05-09 2002-11-20 Millenium Pharmaceuticals, Inc. 63751, ein Mitglied der humanen Zucker-transporterfamilie und seine Verwendungen
EP1386965A4 (de) * 2001-05-10 2004-07-21 Mochida Pharm Co Ltd Neues protein des potentialabhängigen kationenkanals
EP1456397A4 (de) * 2001-07-10 2005-05-11 Millennium Pharm Inc 52908, ein menschlicher kaliumkanal, und verwendungen davon
US20030044933A1 (en) * 2001-08-15 2003-03-06 Millennium Pharmaceuticals, Inc. 96895, a human sodium-hydrogen exchanger family member and uses therefor
WO2003038094A1 (en) * 2001-10-30 2003-05-08 Bayer Healthcare Ag Regulation of human glucose transporter
WO2003037929A1 (en) * 2001-11-01 2003-05-08 Bayer Healthcare Ag Polynucleotides encoding human potassium channel polypeptides
EP1457557A4 (de) * 2001-12-21 2005-12-28 Takeda Pharmaceutical Neue proteine und deren dnas
WO2003056005A1 (fr) * 2001-12-27 2003-07-10 Takeda Chemical Industries, Ltd. Promoteur homologue de sglt humain et utilisation dudit promoteur
EP1473303B1 (de) * 2002-01-18 2010-02-24 Takeda Pharmaceutical Company Limited Natrium abhängiger Gallensäure Transporter und dessen Verwendung
WO2003087158A2 (en) * 2002-04-16 2003-10-23 Bayer Healthcare Ag Regulation of human transient receptor potential channel
EP1557178A4 (de) * 2002-10-29 2009-07-22 Takeda Pharmaceutical Verwendung von sglt-homolog
WO2004081041A1 (en) * 2003-03-10 2004-09-23 Bayer Healthcare Ag Organic anion transporting (oat)-like protein ust3-like1 and uses thereof
WO2005029086A2 (en) * 2003-09-22 2005-03-31 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a10 (ust3-like2) (slc22a10)
CN102656269B (zh) * 2009-09-25 2015-05-13 澳大利亚植物功能基因组学中心有限公司 阳离子通道活性
CA3187837A1 (en) * 2020-08-04 2022-02-10 Exelixis, Inc. Cd47 binding agents and uses thereof
CN115322248B (zh) * 2022-05-18 2024-05-17 大连理工大学 一种钾离子通道蛋白AlAKT1、其编码基因及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2336225A1 (en) * 1998-07-24 2000-02-03 Sagami Chemical Research Center Human proteins having hydrophobic domains and dnas encoding these proteins
US6426197B1 (en) * 1998-11-03 2002-07-30 Smithkline Beecham, P.L.C. Polynucleotides encoding a human potassium channel
CA2349818A1 (en) * 1998-11-04 2000-05-11 Incyte Pharmaceuticals, Inc. Membrane transport proteins
ATE394486T1 (de) * 1998-11-09 2008-05-15 Centre Nat Rech Scient Neue familie von säugetier-kaliumkanälen, ihre klonierung und ihre verwendung, besonders für das drogenscreening
US6664373B1 (en) * 1999-03-01 2003-12-16 Millennium Pharmaceuticals, Inc. TWIK-5 potassium channel polypeptides and uses therefor
US6670149B1 (en) * 1999-03-01 2003-12-30 Millennium Pharmaceuticals, Inc. TWIK-5 potassium channel nucleic acids and uses therefor
CA2395816A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins and antibodies

Also Published As

Publication number Publication date
CA2415808A1 (en) 2002-01-17
WO2002004520A3 (en) 2003-03-20
WO2002004520A2 (en) 2002-01-17
JP2004513618A (ja) 2004-05-13
EP1313854A2 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
AU2001273239A1 (en) Transporters and ion channels
AU2736101A (en) Transporters and ion channels
AU2003228869A1 (en) Transporters and ion channels
AU2001280981A1 (en) Transporters and ion channels
AU2001271839A1 (en) Human ion channels
AU2001230480A1 (en) Broadcast system
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2002241569A1 (en) Transporters and ion channels
AU2002211717A1 (en) Stresscopins and their uses
AU2001291011A1 (en) Transporters and ion channels
AU2001243394A1 (en) Compounds and methods
AU2001265002A1 (en) Transporters and ion channels
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001239860A1 (en) Transporters and ion channels
AU2002256215A1 (en) Transporters and ion channels
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AUPQ872300A0 (en) Compounds and methods
AU2001249906A1 (en) Human transporters and ion channels
AU2003224811A1 (en) Transporters and ion channels
AU2002332573A1 (en) Transporters and ion channels
AU2001278951A1 (en) Compounds and methods
AU2001273069A1 (en) Transporters and ion channels
AU2001264957A1 (en) Human ion channels
AU2001247460A1 (en) 18615 and 48003, human ion channels and uses therefor